
Sun Pharma shares in focus after USFDA nod for next-gen skin disorder device
Shares of Sun Pharmaceutical Industries are set to be in focus on Monday after the company announced that it had received approval from the U.S Food and Drug Administration (USFDA) for its next-generation BLU-U Blue Light Photodynamic Therapy (PDT) device, …